New Australian evidence suggests the protection offered by the monovalent rotavirus vaccine may wane over time and new strains are emerging.

A threefold increase in rotavirus notifications in 2017 prompted Australian epidemiologists to investigate the efficacy of the vaccine (Rotarix) and to characterise circulating strains.